AXSOME THERAPEUTICS, INC. Other Non-Current Assets
AXSOME THERAPEUTICS, INC. (AXSM) had Other Non-Current Assets of $507.46 thousand as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssetsNoncurrent · last filed 2022-08-09
- 2022-06-30: Other Assets, Noncurrent $507.46K.
- 2022-03-31: Other Assets, Noncurrent $322.91K.
- 2021-12-31: Other Assets, Noncurrent $322.91K.
- 2021-09-30: Other Assets, Noncurrent $322.91K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2022-06-30 | $507.46K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $322.91K 10-Q · filed 2022-05-02 |
| 2021-12-31 | $322.91K 10-Q · filed 2022-08-09 |
| 2021-09-30 | $322.91K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $317.38K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $317.38K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $317.38K 10-K · filed 2022-03-01 |
| 2020-09-30 | $317.38K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $139.88K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $143.57K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $139.88K 10-K · filed 2021-03-01 |
| 2019-09-30 | $168.97K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $168.97K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $101.52K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $112.34K 10-K · filed 2020-03-12 |
| 2018-09-30 | $117.36K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $117.36K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $114.89K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $187.95K 10-K · filed 2019-03-15 |
| 2017-09-30 | $119.29K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $119.29K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $119.29K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $112.82K 10-K · filed 2018-03-07 |
| 2016-09-30 | $59.13K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $57.50K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $57.50K 10-Q/A · filed 2016-08-09 |
| 2015-12-31 | $26.63K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |